Prognosis of Parkinson's disease: time to stage III, IV, V, and to motor fluctuations
- PMID: 16763980
- DOI: 10.1002/mds.20993
Prognosis of Parkinson's disease: time to stage III, IV, V, and to motor fluctuations
Abstract
We report a long-term outcome on a large cohort of Japanese patients with Parkinson's disease (PD). A total of 1,768 (793 men, 975 women) consecutive patients visited our clinic from 1 January 1989 to 31 December 2002. Among them, 1,183 patients (531 men, 652 women) came to our clinic within 5 years from the onset of disease and at the Hoehn & Yahr Stage III or less at the first visit. Long-term outcome was evaluated in this subcohort of the patients. We examined the duration to reach Stage III, IV, and V, and the duration to develop wearing off and dyskinesia. Time to reach Stage III was slightly but significantly shorter in women, in that 23.8% of men and 35.3% of women reached Stage III by the end of the 5th year; 49.7% of men and 63.3% of women reached Stage III by the end of the 10th year, and 88.9% of men and 79.9% of women by the end of the 15th year (P < 0.001). Also, durations to develop wearing off and dyskinesia were shorter in women compared to men. These data suggest that the disease progression may be slightly faster for women. Young-onset patients showed significantly longer duration to reach Stage III, IV, and V but shorter duration to develop wearing off and dyskinesia. Not many studies are available in the literature on the long-term outcome of PD, and our data would be useful as a reference.
(c) 2006 Movement Disorder Society.
Similar articles
-
[Progress in the basic and clinical aspects of Parkinson's disease].Rinsho Shinkeigaku. 2004 Nov;44(11):741-50. Rinsho Shinkeigaku. 2004. PMID: 15651281 Review. Japanese.
-
A hospital-based study: risk factors in development of motor complications in 555 Parkinson's patients on levodopa therapy.Clin Neurol Neurosurg. 2006 Dec;108(8):726-32. doi: 10.1016/j.clineuro.2006.02.002. Epub 2006 Mar 27. Clin Neurol Neurosurg. 2006. PMID: 16564615
-
Clinical course of patients with idiopathic Parkinson's disease.Mov Disord. 1996 May;11(3):236-42. doi: 10.1002/mds.870110304. Mov Disord. 1996. PMID: 8723138
-
Motor response to levodopa and the evolution of motor fluctuations in the first decade of treatment of Parkinson's disease.Mov Disord. 2002 Nov;17(6):1227-34. doi: 10.1002/mds.10244. Mov Disord. 2002. PMID: 12465061
-
[Problems of long-term levodopa therapy in Parkinson's disease].Nihon Rinsho. 1997 Jan;55(1):65-71. Nihon Rinsho. 1997. PMID: 9014425 Review. Japanese.
Cited by
-
A Sex Perspective in Neurodegenerative Diseases: microRNAs as Possible Peripheral Biomarkers.Int J Mol Sci. 2021 Apr 23;22(9):4423. doi: 10.3390/ijms22094423. Int J Mol Sci. 2021. PMID: 33922607 Free PMC article. Review.
-
KSNR Clinical Consensus Statements: Rehabilitation of Patients with Parkinson's Disease.Brain Neurorehabil. 2020 May 27;13(2):e17. doi: 10.12786/bn.2020.13.e17. eCollection 2020 Jul. Brain Neurorehabil. 2020. PMID: 36744191 Free PMC article.
-
Efficacy and safety of pramipexole in restless legs syndrome.Curr Neurol Neurosci Rep. 2007 Jul;7(4):273-4. Curr Neurol Neurosci Rep. 2007. PMID: 17618531 No abstract available.
-
Should Exercise Be Prescribed Differently Between Women and Men? An Emphasis on Women Diagnosed With Parkinson's Disease.Front Physiol. 2018 Aug 2;9:1040. doi: 10.3389/fphys.2018.01040. eCollection 2018. Front Physiol. 2018. PMID: 30116203 Free PMC article. No abstract available.
-
Evidence for gender differences in cognition, emotion and quality of life in Parkinson's disease?Aging Dis. 2013 Oct 22;5(1):63-75. doi: 10.14366/AD.2014.050063. eCollection 2014 Feb. Aging Dis. 2013. PMID: 24490118 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical